As of 6 Nov 2026, Healthcare Global Enterprises trades at 845.4× trailing earnings, above the industry P/E of 47.7×, and the shares are 23% below their 52-week high. Its ROCE of 6.7% is the lowest among the 7 largest Medical Care Facilities peers, and sales grew 15% a year over 3 years while net profit fell 22%. Debt is 1.12× equity. It is a small-cap company with a market cap of ₹8,962 Cr, ranked 13th of 40 Medical Care Facilities companies by market cap; the shares fell 20% over the past year.
- ₹599.55
- ₹611.20
- ₹595.00
- ₹610.90
- 99.3K
Health check
- ReturnsBehind
−19.9% over a year, better than 0 of 7 peers.
- Price tagPricier
P/E 845.4 vs industry 47.7.
- GrowthSlow
Sales +14.6%, profit −22.3% a year over 3 years.
- ProfitabilityWeak
ROCE 6.7% vs peer median 11.9%.
- Balance sheetStretched
Debt 1.12× equity, interest covered 1.2×, Piotroski 6 of 9.
- Red flags3 to check
Return on equity is low at 1.8%.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹8,962 Cr
- Small cap
- P/E
- 845.4
- Industry 47.7
- Price to book
- 6.66
- Peers 8.06
- Dividend yield
- 0.00%
- ROE
- 1.8%
- Peers 12.8%
- ROCE
- 6.7%
- Peers 11.9%
- Debt to equity
- 1.12
- Debt ₹1,609 Cr
- EPS (TTM)
- ₹0.71
- Face value ₹10
- OPM (TTM)
- 18.3%
- Net margin 0.4%
- Sales growth
- +13.3%
- Latest quarter vs a year ago
- Profit growth
- +189.9%
- Latest quarter vs a year ago
- Price to sales
- 3.30
- EV/EBITDA 25.3
Strengths and risks
Strengths
- Quarterly profit up 189.9% on a year ago.
- Positive operating cash flow in each of the last 4 years.
Risks to check
- Return on equity is low at 1.8%.
- P/E of 845.4 against an industry P/E of 47.7.
- Interest coverage of only 2.8×.
About Healthcare Global Enterprises
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and…
- Headquarters
- Bengaluru
- Employees
- 6,761
- Sector
- Healthcare
- ISIN
- INE075I01017
- Website
- hcgoncology.com
Price range
- Avg volume (3M)
- 1.6 L
- 1-year return
- minus 19.9%
- From 52-week high
- minus 22.5%
Analyst consensus
Peers · Medical Care Facilities
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSPApollo Hospitals Enterprise | 8,446.00 | plus 0.90% | 1,21,441 | 54.0 | 11.45 | 19.2% | 22.5% | 15.4% | 14.8% | 33.3% | 0.24% | plus 7.2% |
| MAXHEALTHMax Healthcare Institute | 934.00 | plus 0.21% | 90,909 | 66.1 | 8.03 | 12.6% | 12.8% | 26.8% | 22.4% | 9.3% | 0.21% | minus 18.1% |
| MANIPALHOSManipal Health Enterprises | 646.70 | minus 1.61% | 85,065 | 133.6 | 9.05 | 9.8% | 9.2% | 17.8% | – | – | 0.00% | minus 3.0% |
| ASTERDMAster DM Quality Care | 713.15 | minus 0.89% | 62,092 | 90.7 | 8.06 | 9.4% | 9.7% | 17.4% | 15.7% | −3.0% | 0.42% | plus 4.5% |
| FORTISFortis Healthcare | 766.90 | minus 6.45% | 57,898 | 55.7 | 5.52 | 11.9% | 10.4% | 22.2% | 13.3% | 20.9% | 0.13% | minus 19.6% |
| NHNarayana Hrudayalaya | 1,903.00 | minus 0.65% | 38,650 | 44.7 | 7.73 | 11.4% | 19.1% | 18.5% | 20.5% | 9.9% | 0.24% | plus 4.7% |
| MEDANTAGlobal Health | 1,387.60 | minus 0.15% | 37,264 | 60.4 | 8.63 | 15.0% | 15.2% | 22.1% | 17.2% | 19.5% | 0.04% | plus 11.2% |
| HCGHealthcare Global Enterprises | 600.25 | minus 1.74% | 8,962 | 845.4 | 6.66 | 6.7% | 1.2% | 18.3% | 14.6% | −22.3% | 0.00% | minus 19.9% |
| Median of 7 peers | – | −0.65% | 62,092 | 60.4 | 8.06 | 11.9% | 12.8% | 18.5% | 16.5% | 14.7% | 0.21% | 4.5% |
Quarterly results
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|
| 612 | 645 | 631 | 650 | 693 | |
| 504 | 522 | 522 | 525 | 571 | |
| 108 | 123 | 110 | 125 | 122 | |
| 17.6% | 19.1% | 17.4% | 19.2% | 17.6% | |
| 7.5 | 2.9 | 2.4 | 13.6 | 13.1 | |
| 45.5 | 43.6 | 44.8 | 42.7 | 39.9 | |
| 57.9 | 62.8 | 60.7 | 62.8 | 70.4 | |
| – | – | −12.7 | −31.9 | – | |
| 11.9 | 19.8 | −6.1 | 1.3 | 25 | |
| 49.8% | −4.2% | −30.1% | −223.2% | 34.2% | |
| 4.8 | 16.3 | −9.4 | 2.2 | 13.8 | |
| 0.33 | 1.15 | -0.68 | 0.15 | 0.92 |
Profit & loss
- Sales CAGR 3Y
- +14.6%
- Profit CAGR 3Y
- −22.3%
- EPS CAGR 3Y
- −22.8%
- ROE
- 1.8%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 1,676 | 1,890 | 2,201 | 2,522 | |
| – | +12.8% | +16.5% | +14.6% | |
| 1,344 | 1,558 | 1,803 | 2,056 | |
| 332 | 332 | 398 | 466 | |
| 19.8% | 17.6% | 18.1% | 18.5% | |
| 3.6 | 7.3 | 23.5 | −22.2 | |
| 94.4 | 101 | 146 | 168 | |
| 163 | 174 | 211 | 244 | |
| −32.6 | 3.7 | −6.8 | −4.7 | |
| 44.9 | 67.7 | 57 | 26.9 | |
| 60.7% | 39.0% | 14.3% | 15.4% | |
| 29.3 | 48.2 | 44.4 | 13.8 | |
| – | +64.1% | minus 7.8% | minus 69.0% | |
| 2.09 | 3.41 | 3.12 | 0.96 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 139 | 139 | 139 | 149 | |
| 721 | 686 | 783 | 1,183 | |
| 901 | 1,274 | 1,837 | 1,735 | |
| 554 | 607 | 784 | 855 | |
| 2,316 | 2,707 | 3,543 | 3,923 | |
| 1,371 | 1,572 | 2,002 | 2,104 | |
| 18.2 | 83.2 | 55.2 | 79.5 | |
| 19.8 | 15.6 | 27.8 | 29 | |
| 175 | 273 | 236 | 543 | |
| 732 | 764 | 1,223 | 1,167 | |
| 2,316 | 2,707 | 3,543 | 3,923 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 252 | 285 | 317 | 347 | |
| −133 | −226 | −488 | −177 | |
| −140 | −64 | −42.4 | 241 | |
| −21.5 | −5.2 | −213 | 410 | |
| −133 | −186 | −209 | −292 | |
| 118 | 98.9 | 108 | 55 |
Shareholding pattern
- Promoters64.21%
- Public35.79%
| Quarter | Split | Promoters | Public | Promoter change |
|---|---|---|---|---|
| 30 Sep 2026 | 64.21% | 35.79% | 0.00 | |
| 30 Jun 2026 | 64.21% | 35.79% | 0.00 | |
| 31 Mar 2026 | 64.21% | 35.79% | 0.00 | |
| 27 Mar 2026 | 64.21% | 35.79% | plus 0.44 | |
| 31 Dec 2025 | 63.77% | 36.23% | – |
Major shareholders
Filings & events
News
No recent news coverage found.